Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are covering the firm, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]

Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company. The […]

Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average […]

Shares of HealthStream, Inc. (NASDAQ:HSTM – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation […]

Shares of AXT, Inc. (NASDAQ:AXTI – Get Free Report) have been given an average recommendation of “Buy” by the five brokerages that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued ratings on the stock […]

Shares of Cisco Systems, Inc. (NASDAQ:CSCO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-two brokerages that are presently covering the stock, MarketBeat.com reports. Twelve equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong […]

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received an average rating of “Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat.com reports. Fourteen equities research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have covered the stock in the last […]

Braze, Inc. (NASDAQ:BRZE – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and nineteen have issued a buy recommendation on the company. The average 1 year price objective among brokerages […]

Needham & Company LLC reissued their buy rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a report published on Wednesday morning, Benzinga reports. The brokerage currently has a $84.00 target price on the stock. A number of other research analysts have also recently commented on the stock. Chardan Capital cut their price […]

Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) has earned an average rating of “Hold” from the twelve analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have issued a hold rating, two have given a buy rating and one has assigned a strong buy […]

Shares of Invesco Ltd. (NYSE:IVZ – Get Free Report) have been assigned an average recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and one has issued a buy recommendation on […]

Shares of New Gold Inc. (TSE:NGD – Get Free Report) (ARCA:NGD) have earned an average recommendation of “Buy” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, four have given a buy rating and three have assigned a strong buy […]

Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month […]

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. The average twelve-month […]